industry news

LSPN Boston 2023: Life Science IP Review

“Although CVC and Broad’s CRISPR/Cas9 gene editing patents currently coexist in the US, pending federal circuit appeal, the picture is clearer in the EPO opposition…

BIO Europe, Basel 2023: Our thoughts

#BIO Europe is one of the most important Life Science events for people in the industry to attend. This year was no exception. ERS Senior Director,…
All articles loaded
No more articles to load